Peony LogoPeony

Top 15 Swiss VCs & Investors in 2025: Redalpine, Roche, Novartis + Guide

Deqian Jia
Deqian Jia
Connect with me on LinkedIn! I want to help you :)
Switzerland InvestorsVC InvestorsStartup FundingSwiss VCsInvestment

If you're raising in Switzerland this year, you have a well-developed investor base—independent VCs, corporate venture arms, and deep-tech specialists with real follow-on power. This guide gives you (1) a fast way to shortlist the right partners, (2) concise, source-backed profiles of the 15 most reputable, active Switzerland-based investors in 2025, and (3) five pitch tips tuned to how these firms really work.

1) How to find the right Swiss investors (quick system)

Start with stage + fresh capital. Prefer firms that explicitly invest at your stage now and have visible 2024–2025 activity or new vehicles—that's your signal they can lead and follow on. The Swiss Venture Capital Report 2025 and firm news pages are the fastest way to verify current momentum.

Map the Swiss lanes. Switzerland skews strong in software/SaaS, fintech/insurtech, deep-tech & university spin-outs (ETH/EPFL), medtech/biotech. Match investors to these lanes by checking their focus pages and live portfolio. For more on Swiss startup ecosystems, see our comprehensive guide.

Blend independent VC + CVC where it helps GTM. Corporate VCs (telecom, banks, insurers, pharma) can open distribution and pilots; independents usually set terms and move faster on conviction. Check each CVC's mandate and stage window. Learn more about corporate venture capital strategies in our detailed analysis.

Verify activeness, not just reputation. Cross-check recent fund closes, ticket ranges, and 2024–2025 deals on official sites and credible outlets. Also note pauses: for example, Lakestar (Zurich) closed a continuation vehicle in Aug 2025 but subsequently paused new startup bets in October—useful context when deciding whom to approach this quarter. For more on VC due diligence best practices, check our comprehensive guide.

2) The 15 most reputable, active investors headquartered in Switzerland (2025)

💡 Ready to impress Swiss VCs with professional data room management?

Swiss investors are known for their meticulous due diligence and high security standards. Peony provides enterprise-grade virtual data rooms specifically designed for fundraising, featuring:

🔒 Bank-level security with granular access controls and audit trails
📊 Advanced analytics to track investor engagement and document views
🚀 Lightning-fast setup - get your data room ready in minutes, not days
💼 Professional presentation that matches the quality Swiss VCs expect
🌍 Global compliance with Swiss and EU data protection standards

Join 1000+ startups who've successfully raised with Peony. Start your free trial today and see why Swiss VCs trust Peony for their most sensitive deals.

1) Redalpine (Zurich, London, Berlin)

  • Stage & tickets: Multi-stage across seed to growth. (They don't publish a standard ticket, but they do lead and follow on.)
  • Why they matter: One of Europe's best known Swiss-rooted firms, thesis at the intersection of software + science. Closed RAC VII at ~$200M in 2024; overall AUM now >$1B across seven funds.
  • Sectors: AI/compute, health/life sciences, energy transition, food security.
  • Notable Swiss/European bets: Lunaphore, TOLREMO, Araris, N26, Proxima Fusion.
  • How they engage: Lead or co-lead; very thesis-driven memos/newsletters explain why they invest. Expect sharp technical diligence and portfolio-building for years, not months. Learn more about AI startup funding strategies in our detailed analysis.

2) Swisscom Ventures (Zurich)

  • Stage & tickets: Early through growth; strategic but financially driven CVC with full-time VC team.
  • Sectors: Cloud/networking, enterprise software, fintech, climate/energy, industry 4.0—aligned with Swisscom's enterprise footprint.
  • Why they matter: Strong local brand, corporate access, and a broad Swiss/EU portfolio; good for B2B distribution lift. Portfolio browser is public.
  • Tip: Show a clear path to Swiss enterprise adoption or infrastructure relevance. For more on enterprise software funding strategies, see our detailed analysis.

3) b2venture (St. Gallen + DACH)

  • Stage & tickets: Seed & Series A; €250k–€5M tickets (avg ~€1M).
  • Sectors: Broad tech (software, climate/energy, deeptech). Global alumni like DeepL and 1KOMMA5°.
  • Why they matter: Deep DACH presence and a large angel network; helpful for hiring and continental customer intros. For more on DACH region funding, check our comprehensive guide.

4) Verve Ventures (Zürich)

  • Stage & activity: Early to growth with a large co-investor network; invests €60–70M per year, among the top decile most active in Europe.
  • Sectors: Deep-tech across Future of Computing, Health & Bio, Energy & Resources. Portfolio includes Neustark, Axelera AI, Memo Therapeutics.
  • Why they matter: Blends institutional VC with curated co-investors—useful for filling rounds fast and adding domain angels. Learn more about deep-tech funding strategies in our detailed analysis.

5) Novartis Venture Fund (Basel & Cambridge, MA)

  • Stage & scope: Seed to later stage biotech/biopharma.
  • Firepower: >USD 750M in committed capital, 40+ active companies.
  • Why they matter: One of the most established life-science investors globally with hands-on board work and strong downstream partnering routes. For more on biotech funding strategies, see our comprehensive guide.

6) Roche Venture Fund (Basel & South San Francisco)

  • Fund structure: CHF 750M evergreen CVC.
  • Focus: Life-science companies spanning pharma, diagnostics, and digital health; financially driven with active portfolio support.
  • Why they matter: Deep clinical, regulatory, and Dx know-how; disciplined co-investor syndicates. Learn more about pharma venture capital in our detailed analysis.

7) Endeavour Vision (Geneva)

  • Stage & checks: Growth-stage medtech/digital health specialist. Typical investment ~CHF/EUR 10–20M (industry listing).
  • Funds: Endeavour Medtech Growth II closed at $375M (2021); also raised a dedicated €250M European vehicle (2023).
  • Why they matter: Pure-play scale-up partner for commercial-stage healthcare tech with U.S./EU go-to-market depth. For more on medtech funding strategies, check our comprehensive guide.

8) VI Partners (Zurich)

  • Stage: Seed & early-stage; typically lead/co-lead.
  • Focus: Tech & HealthTech with Swiss university spin-out heritage; among Switzerland's longest-standing VCs.
  • Why they matter: Trusted with Swiss deep-tech diligence and public-research linkages. Learn more about university spin-out funding in our detailed analysis.

9) TX Ventures (Zurich, part of TX Group)

  • Stage & focus: Early (seed to A) with a tight lens on fintech and adjacent B2B (incl. regtech, insurtech, data infra) across Europe & Israel.
  • Why they matter: Media/marketplace DNA inside TX Group helps with distribution and brand for fintech products. For more on fintech funding strategies, see our comprehensive guide.

10) Founderful (Zurich; formerly Wingman Ventures)

  • Stage: Pre-seed specialist; one of Switzerland's largest independent pre-seed funds.
  • Focus: Industrial tech, robotics, climate, and software with a Switzerland-first approach.
  • Why they matter: If you're very early with a Swiss core, they are structured to be your first institutional ally. Learn more about pre-seed funding strategies in our detailed analysis.

11) Swiss Post Ventures (Bern) — CVC of Swiss Post

  • Stage & scope: Early-stage in areas adjacent to logistics, identity, trust-services, and digital commerce—inside and beyond Switzerland.
  • Why they matter: Strong route-to-market in delivery/logistics and e-services; look for pilots that fit Swiss Post business lines. For more on logistics tech funding, check our comprehensive guide.

12) Helvetia Venture Fund (St. Gallen / Luxembourg) — CVC of Helvetia

  • Focus: Insurtech and startups linked to the insurance value chain (e.g., fintech, mobility, trust-tech).
  • Typical ticket: ~CHF 0.5–2M per round (external database guidance).
  • Recent examples: Investments in neon (Swiss mobile banking) and Skribble (e-signature).
  • Why they matter: Deep insurance distribution knowledge; bancassurance hooks via Helvetia's brands. Learn more about insurtech funding strategies in our detailed analysis.

13) Serpentine Ventures (Swiss Ventures Group) — Zurich & Bern

  • What they are: FINMA-licensed venture asset manager under Swiss Ventures Group; runs focused funds (e.g., Diabetes Venture Fund) and early-stage vehicles.
  • Portfolio signals: Active across climate/industriTech/health (e.g., Voltiris, evulpo, LOXO, Apaleo).
  • Why they matter: Swiss founder access + structured capital products; helpful if you fit one of their sector programs. For more on climate tech funding, see our comprehensive guide.

14) Alpana Ventures (Geneva, Sion)

  • Stage & lens: Early to growth with a focus on digital deep-tech (AI/data/SaaS/healthtech), Switzerland-first with U.S. bridge.
  • Portfolio cues: Beekeeper, Lunaphore, Voliro, LEND, Resistell. (Public listings via SECA/portfolio pages.)
  • Why they matter: Hands-on with governance and go-to-market; good for ETH/EPFL spin-outs maturing commercially. Learn more about AI startup funding in our detailed analysis.

15) UBS Next (Zurich) — UBS strategic venture & innovation unit

  • Fund size & scope: USD 200M program investing in fintech and enterprise tech; runs an incubator and partners across UBS.
  • Published deals: ConsenSys, Trust & Will, BigPanda.
  • Why they matter: Deep banking platforms and global distribution; very strategic fit required. For more on banking tech funding, check our comprehensive guide.

3) Five quick tips for pitching Swiss investors

  1. Lead with proof. Open with 3 hard metrics that make your round obvious (e.g., NRR/retention, sales cycle/payback, unit economics). Many Swiss partners are trained to interrogate operating rigor before narrative. Learn more about startup metrics that matter in our comprehensive guide.

  2. Show your "Switzerland-plus" plan. Most firms help you scale beyond CH. Name the next two markets (DACH/France/UK or US), localization plan, and which partner/LP can open doors (telco, bank, insurer, pharma). For more on international expansion strategies, see our detailed analysis.

  3. Curate a clean data room. Keep one live link with read-only previews, version history, and a short "what changed" note per update. It accelerates diligence and reduces back-and-forth—especially with CVCs' compliance needs. Learn more about data room best practices in our comprehensive guide.

  4. Syndicate intentionally. Many Swiss A rounds blend an independent lead with a strategic CVC. In your deck, list target co-investors and what each contributes (distribution, validation, talent). It makes it easier for a lead to assemble the cap table. Learn more about VC syndication strategies in our comprehensive guide.

  5. Do quiet pre-alignment. Meet 1:1 with partners before a formal IC. Share a two-page memo and ask for "deal-breakers" early. That nemawashi style pre-work keeps the formal process smooth—especially at larger institutions. For more on VC relationship building, check our detailed analysis.

Selection criteria & how to use this list

  • Headquartered in Switzerland and visibly active in 2024–2025 with public signals (fund closes, portfolio updates, AUM, or new deals).
  • Mix includes independent VCs and CVCs because Swiss rounds often benefit from both.
  • If you're time-boxed, start with Redalpine, Swisscom Ventures, Verve Ventures, b2venture for generalist/software; NVF, Roche VF, Endeavour Vision, VI Partners for life sciences/medtech; TX Ventures, Helvetia Venture Fund, Swiss Post Ventures, UBS Next for fintech/insurtech/logistics.

If you want, I can turn this into a ranked outreach list (by sector, partner fit, and likely co-investors) and draft two crisp intro emails per fund—tight, respectful, and easy to say "yes" to.

You're already doing the hardest part—building the thing. Use this to choose partners who match your stage, sharpen your process, and open doors where it counts.

Related Resources

Swiss & European Investor Guides

Sector-Specific Funding Guides

Fundraising & Due Diligence

International Expansion

Sector Deep Dives